Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:HUM
  • CUSIP: 44485910
  • Web: www.humana.com
Capitalization:
  • Market Cap: $35.52 billion
  • Outstanding Shares: 144,517,000
Average Prices:
  • 50 Day Moving Avg: $245.62
  • 200 Day Moving Avg: $236.63
  • 52 Week Range: $165.03 - $259.76
P/E:
  • Trailing P/E Ratio: 20.22
  • Foreward P/E Ratio: 19.98
  • P/E Growth: 1.58
Sales & Book Value:
  • Annual Revenue: $53.87 billion
  • Price / Sales: 0.66
  • Book Value: $75.79 per share
  • Price / Book: 3.24
Dividend:
  • Annual Dividend: $1.60
  • Dividend Yield: 0.7%
Profitability:
  • EBITDA: $2.66 billion
  • Net Margins: 3.37%
  • Return on Equity: 15.85%
  • Return on Assets: 5.76%
Debt:
  • Debt-to-Equity Ratio: 0.39%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
Misc:
  • Average Volume: 1.08 million shs.
  • Beta: 0.86
  • Short Ratio: 3.51
 

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a dividend on Thursday, August 17th. Stockholders of record on Friday, September 29th will be given a dividend of $0.40 per share on Monday, October 16th. The ex-dividend date of this dividend is Thursday, September 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana announced that its board has approved a share buyback plan on Tuesday, April 11th 2017, which authorizes the company to buyback $2,250,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 7.3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, August, 2nd. The company reported $3.49 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same quarter last year, the business earned $2.30 EPS. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Friday, September, 1st. The company provided earnings per share guidance of ~$11.50 for the period, compared to the Thomson Reuters consensus estimate of $11.51.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

20 analysts have issued 1-year target prices for Humana's stock. Their predictions range from $200.00 to $300.00. On average, they anticipate Humana's share price to reach $253.11 in the next twelve months. View Analyst Ratings for Humana.

What are analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

  • 1. According to Zacks Investment Research, "Humana is well poised to grow on its strong government business. Its top-line has been witnessing an uptrend from past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remains a positive.  Following its strong second-quarter 2017 results, it raised its 2017 adjusted EPS guidance. The company has also seen the Zacks Consensus Estimate for the current year earnings being revised upward in last 30 days. Although the shares have performed in line with the industry in a year's time, its strong fundamentals are likely to help the stock in gaining momentum going forward. However, the company's individual commercial business has remained a drag over past few years. The company will release third quarter results on Nov 8, 2017." (10/17/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board
  • Bruce D. Broussard, President, Chief Executive Officer, Director
  • Brian A. Kane, Chief Financial Officer, Senior Vice President
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Who owns Humana stock?

Humana's stock is owned by many different of retail and institutional investors. Top institutional investors include APG Asset Management N.V. (0.31%), PGGM Investments (0.12%), Robeco Institutional Asset Management B.V. (0.09%), Hermes Investment Management Ltd. (0.06%), Shell Asset Management Co. (0.05%) and State Treasurer State of Michigan (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Quotient Investors LLC, State Treasurer State of Michigan, Quantitative Systematic Strategies LLC, Baker Ellis Asset Management LLC and Rockefeller Financial Services Inc.. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was acquired by a variety of institutional investors in the last quarter, including APG Asset Management N.V., PGGM Investments, Shell Asset Management Co., Hermes Investment Management Ltd., Robeco Institutional Asset Management B.V., Oakbrook Investments LLC, Mutual of America Capital Management LLC and Eqis Capital Management Inc.. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $245.81.


MarketBeat Community Rating for Humana (NYSE HUM)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  540 (Vote Outperform)
Underperform Votes:  642 (Vote Underperform)
Total Votes:  1,182
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $253.11 (2.97% upside)
Consensus Price Target History for Humana (NYSE:HUM)
Price Target History for Humana (NYSE:HUM)
Analysts' Ratings History for Humana (NYSE:HUM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$300.00N/AView Rating Details
10/13/2017Jefferies Group LLCReiterated RatingHold$257.00N/AView Rating Details
10/10/2017Royal Bank Of CanadaReiterated RatingHold$245.00N/AView Rating Details
10/9/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$253.00N/AView Rating Details
9/20/2017Cowen and CompanyReiterated RatingOutperform$230.00 -> $275.00MediumView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$269.00 -> $276.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$234.00 -> $243.00LowView Rating Details
8/3/2017Cantor FitzgeraldReiterated RatingNeutral$200.00 -> $223.00LowView Rating Details
8/3/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$236.00 -> $255.00MediumView Rating Details
8/3/2017Credit Suisse GroupReiterated RatingOutperform$250.00 -> $260.00HighView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017Barclays PLCReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna Bancshares IncReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for Humana (NYSE:HUM)
Earnings by Quarter for Humana (NYSE:HUM)
Earnings History by Quarter for Humana (NYSE HUM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017$3.25N/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Humana (NYSE:HUM)
2017 EPS Consensus Estimate: $10.86
2018 EPS Consensus Estimate: $12.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.18$3.44$3.30
Q4 20174$2.05$2.56$2.22
Q1 20181$2.74$2.74$2.74
Q2 20181$3.41$3.41$3.41
Q3 20181$3.58$3.58$3.58
Q4 20181$2.47$2.47$2.47
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Humana (NYSE:HUM)
Most Recent Dividend:10/16/2017
Annual Dividend:$1.60
Dividend Yield:0.65%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:13.06% (Trailing 12 Months of Earnings)
13.83% (Based on This Year's Estimates)
13.01% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE HUM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/17/2017$0.409/28/20179/29/201710/16/2017
8/17/2017quarterly$0.400.65%9/28/20178/29/201710/27/2017
4/20/2017quarterly$0.400.75%6/28/20176/30/20177/31/2017
2/15/2017quarterly$0.400.78%3/29/20173/31/20174/28/2017
10/26/2016quarterly$0.290.67%1/10/20171/12/20171/27/2017
8/25/2016quarterly$0.290.65%10/11/201610/13/201610/28/2016
4/21/2016quarterly$0.290.66%6/28/20166/30/20167/29/2016
2/18/2016quarterly$0.290.7%3/29/20163/31/20164/29/2016
10/29/2015quarterly$0.290.65%12/28/201512/30/20151/29/2016
8/27/2015quarterly$0.290.63%9/28/20159/30/201510/30/2015
4/17/2015quarterly$0.290.65%6/26/20156/30/20157/31/2015
2/18/2015quarterly$0.280.73%3/27/20153/31/20154/24/2015
10/31/2014quarterly$0.280.81%12/29/201412/31/20141/30/2015
8/27/2014quarterly$0.280.88%9/26/20149/30/201410/31/2014
4/30/2014quarterly$0.281.02%6/26/20146/30/20147/25/2014
2/19/2014quarterly$0.271.06%3/27/20143/31/20144/25/2014
10/30/2013quarterly$0.271.17%12/27/201312/31/20131/31/2014
8/22/2013quarterly$0.271.14%9/26/20139/30/201310/25/2013
4/25/2013quarterly$0.271.47%6/26/20136/28/20137/26/2013
2/27/2013quarterly$0.261.52%3/26/20133/28/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)
Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 95.11%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)
Insider Trades by Quarter for Humana (NYSE:HUM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.00View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.42View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.58View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.00View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.20View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.00View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.00View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
Source:
Loading headlines, please wait.

Social

Chart

Humana (HUM) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.